SRPT
Sarepta Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.11
−2.71%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.17
- Revenue estimate
- $354.7M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.05
- EPS estimate
- $0.22
- Revenue actual
- $401.3M
- Revenue estimate
- $366.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -55.4%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $24
- PT range
- $20 – $27
- Analysts
- 2
1 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.22 | -$0.05 | Miss -123.01% | $401.3M |
| May 6, 2026 | $0.98 | $3.16 | Beat 223.77% | $730.8M |
| Feb 25, 2026 | -$0.71 | -$3.58 | Miss -404.23% | $442.9M |
| Aug 6, 2025 | $1.11 | $2.02 | Beat 81.98% | $611.1M |
| Feb 26, 2025 | $1.38 | $1.50 | Beat 8.70% | $658.4M |
| May 1, 2024 | $0.10 | $0.73 | Beat 625.65% | $413.5M |
| Feb 28, 2024 | $0.01 | $0.47 | Beat 3084.28% | $396.8M |
| Nov 1, 2023 | -$1.66 | -$0.46 | Beat 72.29% | $331.8M |
| Aug 2, 2023 | -$1.89 | -$0.27 | Beat 85.71% | $261.2M |
| May 2, 2023 | -$1.46 | -$0.97 | Beat 33.56% | $253.5M |
| Feb 28, 2023 | -$1.28 | -$1.24 | Beat 3.13% | $258.4M |
| Nov 2, 2022 | -$1.21 | -$2.94 | Miss -142.98% | $230.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026